Li Yong-Hao, Zheng Chu-Run, Liu Yue, Wang Ke, Zhou Fan-Fan, Dong Xin, Yuan Tao, He Qiao-Jun, Zhu Hong, Yang Bo
Institute of Pharmacology & Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
National Health Commission (NHC) Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, 214063, China.
Acta Pharmacol Sin. 2025 Mar 25. doi: 10.1038/s41401-025-01537-3.
Tumor metastasis is an important event in cancer progression, representing an enduring and irrevocable hallmark of cancers. The causes of tumor metastasis are complex and diverse. Arising evidence shows that the dysregulation of calcium signaling plays a crucial role in its initiation and progress. Calcium is an essential secondary messenger that regulates signaling pathways associated with tumor metastasis. The transient accumulation of calcium potentially promotes the advancement of tumor metastasis, while calcium-dependent proteins and calcium-related channels also significantly contribute to such malignant process. Thus, compounds specially targeting calcium channels, transporters or pumps may be therapeutic approaches prohibiting tumor metastasis. This review focuses on exploring the roles of calcium ions, calcium-dependent proteins and calcium-related channels in organotropic metastasis of cancer and its clinical applications in the treatment of metastatic cancers.
肿瘤转移是癌症进展中的一个重要事件,是癌症持久且不可逆转的标志。肿瘤转移的原因复杂多样。越来越多的证据表明,钙信号失调在其起始和进展中起关键作用。钙是一种重要的第二信使,可调节与肿瘤转移相关的信号通路。钙的瞬时积累可能促进肿瘤转移的进展,而钙依赖性蛋白和钙相关通道也对这种恶性过程有显著贡献。因此,专门针对钙通道、转运体或泵的化合物可能是阻止肿瘤转移的治疗方法。本综述着重探讨钙离子、钙依赖性蛋白和钙相关通道在癌症器官特异性转移中的作用及其在转移性癌症治疗中的临床应用。